Why Your Home Health PDGM Reimbursement Dropped Even Though Acuity Didn't

Your PDGM reimbursement dropped not because your patients got healthier, but because CMS recalibrated the case-mix weights, functional impairment levels, and comorbidity adjustment subgroups in a budget-neutral way for CY 2026 — shifting dollars away from many clinical groups regardless of what your agency actually treated.

For multi-site home health agencies and PE-backed post-acute groups running high Medicare episode volume, that recalibration is not a rounding error: CMS's own CY 2026 final rule drops the national standardized 30-day payment rate by close to $19 per episode, before any agency-level coding variance is even factored in. Specialized home health medical billing support is built specifically to isolate that gap before it compounds across a multi-site portfolio.

The Recalibration Nobody Told You About

Every year, CMS rebuilds all 432 PDGM payment groups using the most recent complete claims data — for CY 2026, that's calendar year 2024 utilization. This isn't a rate cut applied evenly. It's a fixed-effects regression model that reassigns relative value across groups.

Your agency's documented acuity can stay identical to last period. But if CMS determined that your specific combination of clinical group, functional impairment level, and comorbidity tier is now worth less relative to other groups, your case-mix weight shrinks — and so does the payment tied to it.

Budget Neutrality Means Someone Has to Lose

CMS applies a case-mix budget neutrality factor (1.0051 for CY 2026) to keep the recalibration cost-neutral in aggregate. That means gains in some payment groups are offset by losses in others.

Add the finalized permanent adjustment of roughly -1% and a temporary adjustment near -3%, both layered on top of the market basket update, and the net national payment rate moves in the opposite direction of your documented case volume — even for agencies whose acuity mix hasn't shifted at all. Distinguishing this model-driven reduction from an appealable, coding-driven one is exactly the judgment call good denial management is built around.

LUPA Thresholds Are Moving Under You

LUPA threshold recalibration is where a lot of unexplained revenue disappears. CMS reset the minimum visit count required to avoid a Low Utilization Payment Adjustment for dozens of case-mix groups using the same 2024 data.

If your visit patterns stayed level but the threshold for your group rose, episodes that used to clear LUPA now fall into it — converting a full 30-day case-mix payment into a low, per-visit payment. Your clinical documentation never changed. The bar it has to clear did. Disciplined payment posting is often the first place this kind of LUPA-driven shortfall becomes visible against the expected remittance.

Admission Source and Timing Are Doing More Work Than You Think

PDGM classifies every 30-day period by clinical group, admission source (institutional vs. community), episode timing (early vs. late), functional level, and comorbidity adjustment. A miscoded admission source or timing flag — institutional coded as community, or a second period miscoded as early — silently drops the period into a lower-weighted group. Accurate charge entry at intake is what keeps admission source and episode timing correct before either ever reaches the HIPPS code.

This is rarely a clinical error. It's an intake or OASIS documentation gap that never touches the chart note but directly touches the HIPPS code and the payment attached to it. Persistent AR follow-up is what catches this kind of gap while there is still time to correct and rebill it.

Why Generic RCM Vendors Miss This

Most billing vendors and in-house EMR reporting track revenue at the aggregate level — total collections, total denials per 12 months. That view cannot separate a CY 2026 model-driven decline from a coding-driven one, because both look identical on a revenue trend line. Dedicated outsourced medical billing services close that blind spot by tracking PDGM variables at the episode level instead of the aggregate.

Episode-level PDGM variable tracking is what surfaces the difference: it isolates case-mix weight, functional level, comorbidity subgroup, admission source, and LUPA status per period, so a multi-site agency can see exactly which episodes lost value to recalibration and which are still recoverable through coding correction. This kind of episode-level oversight is what comprehensive RCM services are built to provide, not a specialty report bolted onto aggregate billing.

Where the Recalibration Hits Hardest

Diagnostic Checklist Before You Assume Coding Error

Key Takeaways

• The CY 2026 recalibration redistributes PDGM payment value across all 432 groups using budget-neutral math — acuity can hold steady while your group's weight declines.
• LUPA threshold shifts convert marginal episodes from case-mix to per-visit payment without any change in clinical documentation.
• Admission source, episode timing, and comorbidity subgroup coding errors produce payment drops that look identical to a real acuity decline.
• Agencies need episode-level PDGM variable tracking, not just aggregate revenue trend review, to tell model-driven loss apart from coding-driven loss.

MBC Spotlight

MBC's home health specialists reconcile every 30-day period against its assigned PDGM clinical group, functional level, comorbidity subgroup, admission source, and LUPA status — separating true CY 2026 recalibration impact from recoverable coding and OASIS documentation errors. Agencies working with MBC have maintained a 97% clean claim rate and a 98% client retention rate across 25+ years of post-acute billing operations.

Because case-mix and LUPA exposure varies by agency, MBC's medical billing pricing is fully custom-quoted rather than a flat rate.

Request a Revenue Diagnostic to see which portion of your PDGM decline is model-driven and which portion is still recoverable.